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Abstract
Background/Objectives Choroidal thinning has been suggested in Leber’s hereditary optic neuropathy (LHON). No study
has been conducted of the choroid in relation to the retinal ganglion cell-inner plexiform layer (RGC-IPL). We sought to
measure choroidal thickness in chronic LHON and to correlate thickness changes with the RGC-IPL.
Subjects/Methods Chronic LHON, 11778 mitochondrial DNA (mtDNA) mutation, patients (26 eyes; mean age: 35.1 ± 16.1
years) were prospectively recruited at Doheny Eye Center, University of California Los Angeles from March 2016 to July 2017.
Age-matched healthy controls (27 eyes; mean age: 32.4 ± 11.1 years) were enroled for comparison. Swept-source optical coherence
tomography (SS-OCT) imaging was performed in chronic LHON patients and compared with age-matched healthy controls.
Results The macular choroid was significantly thinner in chronic LHON (250.5 ± 62.2 μm) compared with controls (313.9 ±
60.2 μm; p < 0.0001). The peripapillary choroid was also significantly thinner in chronic LHON (135.7 ± 51.4 μm) compared
with controls (183.0 ± 61.8 μm, p < 0.001). Choroidal thickness strongly correlated with retinal nerve fibre layer (RNFL)
thickness in both the macular (R2= 0.72; 95% CI, 0.57–0.84) and peripapillary regions (R2= 0.53; 95% CI, 0.31–0.70).
Choroidal thickness was also significantly correlated with macular RGC-IPL thickness (R2= 0.51; 95% CI, 0.26–0.73).
Conclusions Choroidal thinning in chronic LHON correlated strongly with both RNFL and RGC-IPL thicknesses. These
findings may suggest a pathophysiological mechanism involving vascular pathology of the choroid in relation to the retinal
ganglion cell complex in LHON.
Introduction
Leber’s hereditary optic neuropathy (LHON) is a rare,
maternally inherited mitochondrial disease that may be char-
acterized by bilateral loss of vision with a gender distribution
ratio as high as 9:1 between males and females, respectively
[1–4]. Three mitochondrial mutations at nucleotide positions
m.11778G >A, m.3460G >A m.11484T > C result in defec-
tive subunit expression of complex I protein in the electron
transport chain, and account for ~90% of LHON cases [4–8].
Characteristic patterns of retinal nerve fibre layer (RNFL)
thickening from nerve fibre swelling in early or acute stages
of LHON followed by RNFL thinning from decreased nerve
fibre swelling in late or chronic stages of LHON have been
observed [9–11]. Acute LHON has been characterized by
significant nerve fibre thickening in the superior and inferior
quadrants followed later by swelling of nasal fibres, while in
chronic LHON there is differential preservation of the nasal
nerve fibres [4–6].
Aside from these structural nerve fibre changes, optical
coherence tomography (OCT) studies have also suggested
vascular pathology in LHON. Our laboratory recently
demonstrated that RNFL thickening in acute LHON is
accompanied by choroidal thickening, and RNFL thinning
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in chronic LHON is similarly accompanied by choroidal
thinning [11]. This study also showed a direct correlation
between RNFL and choroidal thicknesses in LHON, sug-
gesting that RNFL thickness may be associated with
changes in the choroid [11]. These findings suggest that
while LHON has been shown to involve the retinal ganglion
cells (RGCs) and their axons in the optic nerve
[5, 6, 12, 13], a vascular aetiology may also be involved.
More recent studies conducted by our group revealed that
the macular RGC-inner plexiform layer (RGC-IPL) thick-
ness changes may precede the wave of peripapillary RNFL
swelling classically seen in acute LHON [14]. Given this
earlier involvement, we proposed that the RGC-IPL might
serve as a more sensitive marker for assessing and mon-
itoring disease progression [14, 15]. These retinal and
choroidal studies were predominantly performed using a
spectral domain OCT (SD-OCT) device. Recent advances
in ocular imaging with the introduction of swept-source
OCT (SS-OCT) have enabled clinicians to visualize the
retinal and choroidal structures with greater detail, resolu-
tion, and penetrance compared with previous OCT imaging
modalities [16]. In the present study, we explored the
relationship between inner retinal layer thicknesses, mainly
RGC-IPL, and the choroid in chronic LHON using SS-
OCT. We hypothesized that in the chronic disease stages of
LHON, choroidal thickness would be significantly reduced
and these thickness changes would correlate with that of the
macular RGC-IPL and RNFL thickness.
Methods
Twenty-six LHON patients (mean age: 35.1 ± 16.1 years)
with disease duration >12 months were recruited for the study
at Doheny Eye Center, University of California Los Angeles
(UCLA) from March 2016 to July 2017. The study was
approved by the Institutional Review Board at UCLA.
Informed consent was obtained from all subjects and the study
was conducted in accordance with the Declaration of Helsinki.
All LHON subjects included in this study had a genetically
confirmed diagnosis of LHON, 11778 mitochondrial DNA
(mtDNA) mutation. Subjects with confounding retinal
pathology, optic nerve disease besides LHON, or systemic
conditions potentially affecting the vascular system (e.g.
autoimmune condition, diabetes, and uncontrolled systemic
hypertension) were excluded. All subjects underwent exten-
sive ophthalmologic characterization, including best corrected
visual acuity (BCVA) measurement with the Early Treatment
Diabetic Retinopathy Study chart, expressed as a logarithm of
the minimum angle of resolution (logMAR), slit-lamp bio-
microscopy, intraocular pressure (IOP) measurement, and
dilated fundus examination. For each LHON patient, images
of both eyes were initially acquired. Given the symmetry of
disease and statistical indifference upon inclusion of both eyes
in the analysis, we randomly selected and included only the
right eye for analysis. Twenty-seven age-matched healthy
controls (27 eyes) (mean age: 32.4 ± 11.1 years) were iden-
tified and enroled for comparison. Control subjects had nor-
mal ocular examination including an IOP lower than 20mm
Hg, BCVA of 0.0 logMAR with a refractive error between
−3.00 and +3.00 spherical equivalent, no evidence of optic
disk or retinal disease, or systemic conditions that may affect
the vascular system (e.g. autoimmune condition, diabetes, and
uncontrolled systemic hypertension).
Instrumentation and procedures
OCT images were taken using SS-OCT (DRI-OCT, Triton,
Tokyo, Japan). The instrument uses a wavelength of 1050 nm
with a scan speed of 100,000 A-scans per second. The images
were obtained using a 3-dimensional (3D) wide scan protocol
with a size of 12 × 9mm consisting of 256 B-scans, each
comprising 512 A-scans. This allowed obtaining images of the
macular and optic nerve head region in a single scan. The total
acquisition time was 1.3 s per 12 × 9mm scan. Following
proper seating and alignment of each patient, the iris was
brought into view using the mouse-driven alignment system,
and the ophthalmoscopic image was focused. Automated
measurements of the peripapillary and macular choroid were
recorded using a 360° 6-mm diameter circle. The choroid
analysis algorithm processed data from 3D volume scans with
measured thicknesses of the macular and peripapillary choroid.
Choroidal thickness was measured across eight sectors for both
the macular and peripapillary choroid. Subfoveal choroidal
thickness was measured from centring the elliptical annulus on
the fovea (Fig. 1a, b). Mean thickness values for each layer
were calculated for the topographical retinal areas of the
standard grid template centred at the fovea. This included the
central 1 mm region along with the four quadrants of the inner
annular ring (1–3mm radius), and the four quadrants of the
outer annular ring (3–6mm radius) (Fig. 1c, d). RNFL and
RGC-IPL thicknesses were measured using a 360° 3.4-mm
diameter circle scan with thicknesses measured across the
superior, nasal, inferior, and temporal sectors. All images were
acquired by an experienced operator. The built-in SS-OCT
eye-tracking system was used to provide reproducible mea-
surements. The quality of each scan and accuracy of the seg-
mentation algorithm were reviewed by an experienced, blinded
examiner. Images with segmentation failures, significant
motion artefacts, or signal strength less than 6 were excluded.
Statistical methods
Statistical analysis was performed using the Statistical
Package for Social Sciences (version 21 SPSS Inc. Chicago,
IL, USA). A Shapiro–Wilk test was used to evaluate the
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normal distribution of the variables. All variables were
reported as a mean ± standard deviation and compared using
one-way analysis of covariance, including age and gender as
covariates. Given the data did not follow a normal distribu-
tion, a non-parametric Mann–Whitney U test (independent
Studentʼs t test) was performed for pair-wise comparisons.
Pearson correlation was performed between choroidal
thickness and RGCL or RNFL thickness. Statistical sig-
nificance was selected at a p < 0.05.
Results
Demographic data
Table 1 shows the demographic data of chronic LHON
patients and healthy controls. One eye from the LHON
group and two eyes from the age-matched control group
were excluded from analysis due to poor scan quality.
RNFL and RGC-IPL
Mean total RNFL thickness was 50.4 ± 17.8 μm in chronic
LHON patients and 111.3 ± 11.8 μm in control patients (p <
0.005). Mean total RGCL thickness was 43.0 ± 7.1 μm
Table 1 Study participants’ demographic and clinical features
Chronic LHON Healthy controls
Number of participants (number
of eyes)
26 (26) 27 (27)
Gender (number of males) 21 19
Number of smokers 0 0
Age, years 35.1 ± 16.0 32.4 ± 11.1
(p= 0.45)
Disease duration, years 4.5 ± 2.5 –
Visual acuity, logMAR 1.6 ± 0.8 0
Data are shown as mean ± SD
Fig. 1 Imaging of choroidal thickness for the macular and peripapil-
lary regions using swept-source optical coherence tomography
(SS-OCT). a Representative OCT B-scan with b corresponding 360°,
6 mm diameter circle scan centred on the fovea, from a healthy subject
(control group). c Representative OCT B-scan with d corresponding
360°, 6 mm diameter circle scan centred on the optic disk, from a
healthy subject (control group)
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in chronic LHON patients and 86.0 ± 4.1 μm in control
patients (p < 0.005). RNFL and RGC-IPL sectoral analyses
are shown in the Supplementary material.
Choroidal analyses
The macular choroid was markedly thinner in LHON rela-
tive to controls across all measured sectors. As seen in
Table 2, thinning was most pronounced in the subfoveal and
inner superior regions and least pronounced in the outer
temporal region. Similarly, the peripapillary choroid was
significantly thinner in LHON relative to controls across all
measured sectors. As seen in Table 3, thinning was most
pronounced in the superior sector and least pronounced in
the nasal sector.
Pearson correlation testing for the average measurements
of the RNFL and the choroid showed a shared pattern of
thinning in LHON, which was more apparent in the macular
region (Fig. 2a: R2= 0.72; 95% CI, 0.57–0.84) than in
the peripapillary region (Fig. 2b: R2= 0.53; 95% CI,
0.31–0.70). The RGC-IPL was also significantly correlated
with the choroid, although specifically within the macular
region (Fig. 2c: R2= 0.51; 95% CI, 0.26–0.73). The RGC-
IPL and the peripapillary choroid were weakly correlated
(Fig. 2d: R2= 0.34; 95% CI, 0.10–0.55).
Discussion
Our group recently showed a direct in vivo correlation
between RNFL and choroidal thickness in both the macular
and peripapillary regions using an SD-OCT device [11].
The current prospective study uses an SS-OCT device to
quantitatively investigate and compare both RNFL and
RGC-IPL thickness profiles with that of the choroid in
patients with chronic LHON mtDNA 11778. We expand
upon our previous work by demonstrating that, in addition
to the RNFL, choroidal thinning is accompanied by, and
directly correlated with, RGC-IPL thinning.
The RNFL and the choroid were both significantly
thinner and directly correlated in LHON patients. This is
consistent with our previous study, which showed that
RNFL thinning likely starts earlier relative to the choroid,
and that the two entities are directly correlated over the
course of the disease [11]. We found that RNFL thickness
directly correlated with both the macular and peripapillary
choroid, and this correlation was more significant in the
macular region. This further supports our proposed theory
of continual axonal loss in LHON over time [12]. Our
laboratory and others have previously shown that in LHON,
mtDNA point mutations affecting Complex I of the mito-
chondrial respiratory chain impair electron transfer in oxi-
dative phosphorylation. This impairment leads to decreased
energy or ATP production and consequent reactive oxygen
Table 2 Comparison of macular
choroidal thickness between
LHON patients and controls as
measured by swept-source OCT
Sector Chronic LHON Healthy Controls Difference p value
Subfoveal 262.7 ± 73.9 334 ± 71.7 −71.3 ± 15.9 p < 0.0001
IS 260.8 ± 72.1 332.4 ± 67.1 −71.6 ± 15.2 p < 0.0001
IN 248.9 ± 67.4 308.1 ± 73.1 −59.2 ± 15.4 p < 0.0001
II 264.3 ± 74.6 323.1 ± 69.2 −58.8 ± 15.9 p < 0.0001
IT 259.0 ± 70.6 325.9 ± 63.5 −66.9 ± 14.6 p < 0.0001
OS 258.0 ± 73.3 324.6 ± 64.6 −66.6 ± 15.1 p < 0.0001
ON 195.9 ± 61.8 259.2 ± 68.9 −63.3 ± 14.3 p < 0.0001
OI 254.7 ± 69.4 313.2 ± 75.2 −58.6 ± 15.8 p < 0.0001
OT 250.4 ± 64.3 304.4 ± 59.1 −54.0 ± 13.5 p < 0.0001
Average 250.5 ± 62.2 313.9 ± 60.2 −63.4 ± 13.3 p < 0.0001
Data are shown as mean ± SD
IS inner superior, IN inner nasal, II inner inferior, IT inner temporal, OS outer superior, ON outer nasal, OI
outer inferior, OT outer temporal
Table 3 Comparison of peripapillary choroidal thickness between
LHON patients and controls as measured by swept-source OCT
Sector Chronic LHON Healthy
controls
Difference p value
IS 105.4 ± 62.3 164.6 ± 73.0 −59.2 ± 14.8 p < 0.0001
IN 107.2 ± 55.0 134.6 ± 58.22 −27.4 ± 12.4 p < 0.006
II 100.8 ± 44.8 149.3 ± 74.6 −48.5 ± 13.5 p < 0.0001
IT 113.8 ± 54.2 160.4 ± 68.5 −46.6 ± 13.5 p < 0.0001
OS 172.6 ± 61.3 232.3 ± 62.2 −59.7 ± 13.5 p < 0.0001
ON 161.2 ± 57.0 196.3 ± 48.8 −35.1 ± 11.6 p < 0.02
OI 139.8 ± 51.1 187.69 ± 74.6 −47.9 ± 14.0 p < 0.001
OT 184.7 ± 62.3 239 ± 71.2 −54.3 ± 14.6 p < 0.01
Average 135.7 ± 51.4 183.01 ± 61.8 −47.4 ± 12.4 p < 0.0007
Data are shown as mean ± SD
IS inner superior, IN inner nasal, II inner inferior, IT inner temporal,
OS outer superior, ON outer nasal, OI outer inferior, OT outer temporal
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species (ROS) overproduction [12–15, 17, 18]. Studies
conducted by Bonello et al. have demonstrated that ROS
directly link hypoxia inducible factor 1 (HIF-1)-alpha and
nuclear factor kappa light chain enhancer of activated B
cells (NF-kappaB), suggesting the importance of this path-
way in disorders associated with elevated levels of ROS
such as LHON [19]. Given these findings, we propose that
the overproduction of ROS seen with axonal degeneration
in LHON may promote the signalling of angiogenic factors
and contribute to vascular changes of the choroid. Specifi-
cally, a low rate of ongoing axonal degeneration and
overproduction of ROS likely continues vascular signalling,
which may explain the prolonged choroidal remodelling
seen in chronic LHON [11–15, 17–19]. This is surprising in
the peripapillary region insofar as the RNFL is inner retina
and the choroid supplies the outer retina. Alternatively, but
less likely, there was an additional vascular pathology that
paralleled events in the inner retina.
The current study also assessed RGC-IPL thickness in
relation to the choroid. We found that the RGC-IPL was
both significantly thinner and directly correlated with
choroidal thickness in LHON patients. Similar to the RNFL,
RGC-IPL thickness was more closely correlated with
choroidal thickness in the macular region relative to the
peripapillary region. Balducci et al. recently showed that
macular RGC-IPL thickness changes likely precede the
wave of peripapillary RNFL swelling in acute LHON
[20, 21]. Taken together, our findings suggest that a similar
sequence of events continues to occur even in chronic
LHON. In particular, choroidal thinning possibly begins in
the macular region and is later followed by thinning in the
peripapillary region. This notion may likely explain the
greater thickness reduction exhibited in the macular choroid
relative to the peripapillary choroid in chronic LHON.
Alternatively, the central macula, not only having a retinal
blood supply, is more dependent on the choroid.
Fig. 2 Pearson correlation tests between: a retinal nerve fibre layer
(RNFL) and macular choroid thickness, and b RNFL and peripapillary
choroidal thickness in chronic LHON patients. c Retinal ganglion cell-
inner plexiform layer (RGC-IPL) and macular choroid thickness.
d RGC-IPL and peripapillary choroidal thickness in chronic LHON
patients
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Vascular changes including transient peripapillary
microangiopathy and telangiectasias have been well char-
acterized in LHON. However, these features are hallmarks
primarily seen in acute stages of LHON [9–11]. In chronic
stages of LHON, our laboratory recently showed significant
vascular attenuation in the macula using OCT angiography
(OCTA) [22]. Using OCTA in chronic LHON, Borrelli
et al. observed a decrease in retinal perfusion that was most
pronounced in areas of extensive neuronal damage [22].
Previous studies have described a coupling between blood
supply and the energy demands of the retina such that blood
flow is regulated towards functionally active areas of the
retina and diverted away from inactive or damaged areas of
the retina [23–25]. This pairing of blood supply and retinal
metabolism may explain Borrelli et al. findings in chronic
LHON whereby extensive neuronal damage in the retina
may be associated with a reduced metabolic demand and a
corresponding reduction in retinal perfusion [22–25]. Intri-
guingly, our results demonstrated that the greater choroidal
thickness reduction seen in the macular region was topo-
graphically associated with the region occupied by the
papillomacular bundle, which is where mitochondrial dys-
function and ganglion cell loss first occur in LHON [11, 26–
30]. Studies have shown that the overproduction of ROS
from complex I deficiency in LHON leads to the upregu-
lation of trophic factors as similarly seen in hypoxic
ischaemic conditions [12, 15, 18, 19, 31]. Therefore,
choroidal thickness changes in LHON may represent
mitochondrial angiopathy involving angiogenic trophic
factors as a compensatory response to a “pseudo-hypoxic”
state perhaps mediated by ROS [11, 15, 18, 19, 28, 31].
Given a reduced metabolic demand of the macula in chronic
LHON, as previously suggested [22–25], a greater thickness
reduction for the macular choroid was expected and
observed in our study. Since we exclusively assessed
chronic LHON patients exhibiting an advanced loss of
macular ganglion cells, the significant correlation with the
choroid further supports a vascular aetiology involved in the
complex pathophysiology of this disorder.
Conclusions and future directions
The current study provides clues to a more complete
understanding of LHON mechanisms in relation to vas-
cular pathology. We used SS-OCT to assess the choroid at
a greater resolution and depth compared with previous
studies using SD-OCT. In addition, choroidal thickness
measurements were acquired in an automated fashion with
reliable repeatability. Morphological assessment of the
choroid using SS-OCT may offer certain clinical advan-
tages given vascular abnormalities are not only observed
in asymptomatic LHON carriers, but also are associated
with an increased risk of converting to the disease
state [8–10]. The current results may be used as a basis for
future studies evaluating the natural disease course.
Nevertheless, additional studies of choroidal vascular
measures in conjunction with RGC-IPL measurements are
warranted to demonstrate their utility as useful biomarkers
for monitoring the efficacy of purported therapies in
patients with LHON. Since this prospective study was
exploratory and cross-sectional in nature, a power calcu-
lation was not performed and proper characterization of
LHON natural history requires a long-term longitudinal
follow-up study. Future studies may benefit from inves-
tigating correlations between structure and function to
further support choroidal thinning as an important mea-
sure of treatment effect.
Summary
What was known before
● Choroidal thinning has been suggested in LHON.
● This thinning may be related to the neural retina.
However, choroidal thinning in relation to the RGC-IPL
has not previously been studied.
What this study adds
● Choroidal thickness correlates strongly with both RNFL
and RGC-IPL thicknesses in chronic disease.
● Vascular pathology may be involved in LHON
pathophysiology.
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